- Home
- MKTW vs MYO Comparison
MKTW vs MYO Comparison
Compare MKTW & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- MYO
- Stock Information
- Founded
- MKTW 1999
- MYO 2004
- Country
- MKTW United States
- MYO United States
- Employees
- MKTW N/A
- MYO N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- MYO Industrial Specialties
- Sector
- MKTW Technology
- MYO Health Care
- Exchange
- MKTW Nasdaq
- MYO Nasdaq
- Market Cap
- MKTW 48.2M
- MYO 44.6M
- IPO Year
- MKTW N/A
- MYO 2017
- Fundamental
- Price
- MKTW $17.65
- MYO $0.96
- Analyst Decision
- MKTW Hold
- MYO Strong Buy
- Analyst Count
- MKTW 1
- MYO 3
- Target Price
- MKTW $20.00
- MYO $8.17
- AVG Volume (30 Days)
- MKTW 13.9K
- MYO 2.1M
- Earning Date
- MKTW 11-06-2025
- MYO 11-05-2025
- Dividend Yield
- MKTW 4.48%
- MYO N/A
- EPS Growth
- MKTW 59.71
- MYO N/A
- EPS
- MKTW 2.83
- MYO N/A
- Revenue
- MKTW $358,121,000.00
- MYO $40,760,091.00
- Revenue This Year
- MKTW N/A
- MYO $25.69
- Revenue Next Year
- MKTW N/A
- MYO $23.52
- P/E Ratio
- MKTW $6.30
- MYO N/A
- Revenue Growth
- MKTW N/A
- MYO 93.08
- 52 Week Low
- MKTW $9.08
- MYO $0.92
- 52 Week High
- MKTW $21.74
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- MKTW 43.71
- MYO 24.10
- Support Level
- MKTW $17.70
- MYO $0.96
- Resistance Level
- MKTW $18.08
- MYO $1.17
- Average True Range (ATR)
- MKTW 0.40
- MYO 0.08
- MACD
- MKTW -0.03
- MYO 0.02
- Stochastic Oscillator
- MKTW 22.73
- MYO 4.44
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).